Wells Fargo & Company »

Tempest Therapeutics shares owned by Wells Fargo & Company

Quarter-by-quarter ownership of Tempest Therapeutics (TPST) shares owned by Wells Fargo & Company from 13F filings

Historical chart of Wells Fargo & Company investment in Tempest Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Tempest Therapeutics held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tempest Therapeutics by Wells Fargo & Company

Quarter filed Position value Share count Share price at filing
2025-09-30 $30 3 10.33

More positions owned by Wells Fargo & Company

Microsoft Corporation Call Option (MSFT)
Apple Put Option (AAPL)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Ishares Tr Core S&p500 Etf (IVV)
NVIDIA Corporation (NVDA)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Ishares Tr Core S&p Ttl Stk (ITOT)
Broadcom (AVGO)
Ishares Tr Russell 2000 Etf (IWM)
Vanguard Index Fds Mid Cap Etf (VO)
JPMorgan Chase & Co. Put Option (JPM)
Amazon Call Option (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Tr Core Msci Eafe (IEFA)
Meta Platforms Cl A (META)

View all positions for Wells Fargo & Company

Top funds holding Tempest Therapeutics

Vanguard Group
Geode Capital Management
BlackRock
FMR
Belvedere Trading
DRW Holdings
UBS Group
Morgan Stanley
Advisor Group Holdings
Atlantic Trust
Federation des caisses Desjardins du Quebec
SBI Securities
Parallel Advisors
Wells Fargo & Company
Bnp Paribas Arbitrage, Snc

View all funds holding Tempest Therapeutics